4-Aminoquinoline-Based Adamantanes as Potential Anticholinesterase Agents in Symptomatic Treatment of Alzheimer's Disease
Considering that acetylcholinesterase (AChE) inhibition is the most important mode of action expected of a potential drug used for the treatment of symptoms of Alzheimer's disease (AD), our previous pilot study of 4-aminoquinolines as potential human cholinesterase inhibitors was extended to tw...
Saved in:
Main Authors: | Katarina Komatović (Author), Ana Matošević (Author), Nataša Terzić-Jovanović (Author), Suzana Žunec (Author), Sandra Šegan (Author), Mario Zlatović (Author), Nikola Maraković (Author), Anita Bosak (Author), Dejan M. Opsenica (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design, Synthesis and Biological Evaluation of Biscarbamates as Potential Selective Butyrylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease
by: Ana Matošević, et al.
Published: (2022) -
Anticholinesterase and Serotoninergic Evaluation of Benzimidazole-Carboxamides as Potential Multifunctional Agents for the Treatment of Alzheimer's Disease
by: Daria A. Belinskaia, et al.
Published: (2023) -
Adamantane-containing drug delivery systems
by: Stela Dragomanova, et al.
Published: (2023) -
Antioxidant and Anticholinesterase Activities of <i>Macrosphyra Longistyla</i> (DC) Hiern Relevant in the Management of Alzheimer's Disease
by: Taiwo O. Elufioye, et al.
Published: (2019) -
THE ACTIVITY OF 4-AMINOQUINOLINE AGAINST PLASMODIUM FALCIPARUM IN SOUTHERN IRAN
by: AV. Manouchehri, et al.
Published: (1973)